Phreesia (NYSE:PHR) and KORU Medical Systems (NASDAQ:KRMD) Head-To-Head Analysis

Phreesia (NYSE:PHRGet Free Report) and KORU Medical Systems (NASDAQ:KRMDGet Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, dividends, institutional ownership, analyst recommendations, profitability and earnings.

Profitability

This table compares Phreesia and KORU Medical Systems’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Phreesia -1.16% -1.31% -0.94%
KORU Medical Systems -6.41% -15.90% -9.77%

Analyst Ratings

This is a summary of current ratings and recommmendations for Phreesia and KORU Medical Systems, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Phreesia 1 1 17 0 2.84
KORU Medical Systems 1 1 4 0 2.50

Phreesia presently has a consensus target price of $29.12, suggesting a potential upside of 147.47%. KORU Medical Systems has a consensus target price of $6.50, suggesting a potential upside of 46.73%. Given Phreesia’s stronger consensus rating and higher probable upside, equities research analysts plainly believe Phreesia is more favorable than KORU Medical Systems.

Institutional & Insider Ownership

92.1% of Phreesia shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 5.5% of Phreesia shares are held by insiders. Comparatively, 20.6% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Risk & Volatility

Phreesia has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.47, suggesting that its share price is 53% less volatile than the S&P 500.

Valuation and Earnings

This table compares Phreesia and KORU Medical Systems”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Phreesia $419.81 million 1.69 -$58.53 million ($0.10) -117.66
KORU Medical Systems $41.13 million 4.99 -$2.64 million ($0.06) -73.83

KORU Medical Systems has lower revenue, but higher earnings than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than KORU Medical Systems, indicating that it is currently the more affordable of the two stocks.

Summary

Phreesia beats KORU Medical Systems on 9 of the 13 factors compared between the two stocks.

About Phreesia

(Get Free Report)

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

About KORU Medical Systems

(Get Free Report)

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.